Frontiers in Drug Discovery, Год журнала: 2024, Номер 4

Опубликована: Сен. 3, 2024

Antibodies represent the largest class of biotherapeutics thanks to their high target specificity, binding affinity and versatility. Recent breakthroughs in Artificial Intelligence (AI) have enabled information-rich silico representations antibodies, accurate prediction antibody structure from sequence, generation novel antibodies tailored specific characteristics optimize for developability properties. Here we summarize state-of-the-art methods analysis. This valuable resource will serve as a reference application AI analysis sequencing datasets.

Язык: Английский